Clinical Trial Update: A Study of R3421 in Patients With Moderate to Severe Chronic Plaque Psoriasis. [Phase 2]

View source ↗

Summary

Phase 2 study of R3421 in patients with moderate-to-severe chronic plaque psoriasis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plaque Psoriasis

Drugs mentioned

• R3421

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Psoriasis | Phase 2 | Status: COMPLETED